CIK 0000921114
- Non-accelerated filer
- Smaller reporting company
Armata Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ARMP
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 911549568
- Phone
- +1 310-665-2928
- Business address
- 5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
- Former names
- AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
- 4 Shares withheld for taxes President and CEO gave up 7,618 shares (to pay taxes)
- 4 Shares withheld for taxes Vice President and CFO gave up 6,170 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 399 shares at $0.67 ($267)
- 4 Grant or award CFO & VP Finance acquired 35,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 50,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Chairman of the Board acquired 15,000 shares (grant or award)
- 4 Grant or award Executive Vice President acquired 35,000 shares (grant or award)
- 4 Open-market sale 10% owner sold 8,300 shares at $0.91 ($7,550)
- 4 Open-market sale 10% owner sold 200 shares at $0.90 ($180)
- 4 Open-market sale 10% owner sold 12,900 shares at $0.94 ($12,145)
- 4 Open-market sale 10% owner sold 55,200 shares at an average $0.92 ($50,858)
- 4 Open-market sale 10% owner sold 2,371 shares at $1.15 ($2,727)
- 4 Open-market sale 10% owner sold 42,800 shares at $1.15 ($49,203)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CFO & VP Finance acquired 35,000 shares (grant or award)
Page 10 of 14 · 267 filings